Cadence Raises $100 Million to Scale AI Chronic Care for Older Adults

Clinical AI company Cadence raised a $100 million Series C led by Spark Capital to expand AI-powered chronic disease care for older adults across more than 20 health systems.

Cadence Raises $100 Million to Scale AI Chronic Care for Older Adults Clinical AI company Cadence raised a $100 million Series C led by Spark Capital to expand AI-powered chronic disease care for older adults across more than 20 health systems. Aaron Rafferty June 24, 2026 Key Takeaways Cadence, a clinical AI company, raised a $100 million Series C led by Spark Capital at a $1.23 billion valuation. The company uses AI care agents to manage chronic disease for older adults across more than 20 health systems and 100,000 active patients. Cadence says its model saves Medicare about $2.7 million every week as a clinician shortage deepens. Cadence, a clinical AI company that manages chronic care for older adults, raised a $100 million Series C led by Spark Capital, the company announced on June 23, 2026. The round, reported by STAT and Business Wire , values Cadence at about $1.23 billion. Thrive Capital, General Catalyst, Coatue, B Capital, and the venture arms of health systems Corewell Health and Memorial Hermann joined the round, along with Duke Health. Cadence works with more than 20 health systems and treats over 100,000 active patients, using AI agents to monitor blood pressure, diabetes, and other chronic conditions between doctor visits. Chronic conditions like heart failure, hypertension, and type 2 diabetes drive a large share of US health spending, and they require steady monitoring that overworked practices struggle to provide. Cadence's pitch is that AI agents can handle routine check-ins, flag patients who are slipping, and route urgent cases to human clinicians, keeping more people stable at home and out of the hospital. The company says its model saves Medicare roughly $2.7 million every week. The funding targets a widening gap. About 56 million older adu